Nev Black Posted November 24, 2017 Share Posted November 24, 2017 At yesterday's phone-in meeting, the topic of bone protection with Denosumab came up. That reminded me of what Mark Moyad told us when we met with him a few months ago. The clicking on the YouTube video should take you directly to the start of his Denosumab remarks (at 28:40). Transcript of the Denosumab section Next on the line is essentially the bone drugs. What's new and exciting with the bone drugs out there in other words the osteoporosis prevention drugs. I think what continues to excite people is the idea of using a Denosumab or it's called here Xgeva x g e v a as the potential go-to drug in the future to reduce skeletal related events. So, I still think the fact that getting an injection every once in a while versus an IV not only does it seem to be this drug seems to be working better for a lot of men but I think the real excitement will be these drugs sit in the body for so long that I think in the future oncologists are going to space them out even further in some men. I mean, there are women around the world and men around the world that get these injections for osteoporosis right now just one time of year and it is able to maintain their bones capacity. In the United States many women just get it twice a year. They don't need to get it every three weeks or four weeks and the drugs sit in their bodies so long they their done after one or two injections for an entire year. I hope that model moves towards prostate cancer that would be extremely exciting. Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.